102
Participants
Start Date
October 6, 2021
Primary Completion Date
February 1, 2022
Study Completion Date
February 1, 2022
Questionnaire
A questionnaire will be given to patients who will ask them about their possible fractures, their bone and oncological follow-ups and their possible cardiovascular events since the end of treatment with hormone therapy.
CHU Toulouse, Toulouse
University Hospital, Toulouse
OTHER